143 related articles for article (PubMed ID: 18712728)
1. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts.
Hu ZY; Zhu XF; Zhong ZD; Sun J; Wang J; Yang D; Zeng YX
Int J Cancer; 2008 Nov; 123(10):2418-29. PubMed ID: 18712728
[TBL] [Abstract][Full Text] [Related]
2. ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.
Sun J; Li ZM; Hu ZY; Lin XB; Zhou NN; Xian LJ; Yang DJ; Jiang WQ
Anticancer Drugs; 2008 Nov; 19(10):967-74. PubMed ID: 18827561
[TBL] [Abstract][Full Text] [Related]
3. Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagy.
He JH; Liao XL; Wang W; Li DD; Chen WD; Deng R; Yang D; Han ZP; Jiang JW; Zhu XF
Int J Oncol; 2014 Sep; 45(3):1099-108. PubMed ID: 24919770
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
[TBL] [Abstract][Full Text] [Related]
5. ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway.
Hu ZY; Sun J; Zhu XF; Yang D; Zeng YX
J Transl Med; 2009 Aug; 7():74. PubMed ID: 19698176
[TBL] [Abstract][Full Text] [Related]
6. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
[TBL] [Abstract][Full Text] [Related]
7. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
8. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species.
Hu ZY; Wang J; Cheng G; Zhu XF; Huang P; Yang D; Zeng YX
Chin J Cancer; 2011 Jan; 30(1):41-53. PubMed ID: 21192843
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
Li-juan B; Bing L; Zhi L; Yang L; Ying-jie L
Pathol Res Pract; 2009; 205(12):828-37. PubMed ID: 19625133
[TBL] [Abstract][Full Text] [Related]
10. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
[TBL] [Abstract][Full Text] [Related]
11. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.
Sun Y; Wu J; Aboukameel A; Banerjee S; Arnold AA; Chen J; Nikolovska-Coleska Z; Lin Y; Ling X; Yang D; Wang S; Al-Katib A; Mohammad RM
Cancer Biol Ther; 2008 Sep; 7(9):1418-26. PubMed ID: 18769131
[TBL] [Abstract][Full Text] [Related]
12. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo.
Niu X; Li S; Wei F; Huang J; Wu G; Xu L; Xu D; Wang S
Breast Cancer; 2014 Mar; 21(2):223-30. PubMed ID: 22711315
[TBL] [Abstract][Full Text] [Related]
13. ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.
Li T; Yuan G; Zhang L; Ye L; Li S; Fan Y; Sun J
Mol Med Rep; 2015 Nov; 12(5):6976-84. PubMed ID: 26352605
[TBL] [Abstract][Full Text] [Related]
14. Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an
Zheng R; Chen K; Zhang Y; Huang J; Shi F; Wu G; Wang S
Oncol Lett; 2017 Jul; 14(1):751-757. PubMed ID: 28693230
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells.
Banerjee S; Choi M; Aboukameel A; Wang Z; Mohammad M; Chen J; Yang D; Sarkar FH; Mohammad RM
Pancreas; 2010 Apr; 39(3):323-31. PubMed ID: 19823097
[TBL] [Abstract][Full Text] [Related]
17. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
Low SY; Tan BS; Choo HL; Tiong KH; Khoo AS; Leong CO
Cancer Lett; 2012 Jan; 314(2):166-75. PubMed ID: 22033244
[TBL] [Abstract][Full Text] [Related]
18. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.
Cao LH; Li HT; Lin WQ; Tan HY; Xie L; Zhong ZJ; Zhou JH
Sci Rep; 2016 Jan; 6():18706. PubMed ID: 26729257
[TBL] [Abstract][Full Text] [Related]
19. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
[TBL] [Abstract][Full Text] [Related]
20. Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo.
Zhang X; Hu X; Mu S; Zhan Y; An Q; Liu Z; Huang X
Mol Med Rep; 2014 Sep; 10(3):1184-94. PubMed ID: 25060748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
